The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis

被引：0
|
作者：
Zohreh Safipour
Rogier van der Zanden
Joop van den Bergh
Paddy Janssen
Peter Vestergaard
Frank de Vries
Johanna H. M. Driessen
机构：
[1] Curaçao Medical Centre,Department of Clinical Pharmacy
[2] Maastricht University Medical Centre,Department of Clinical Pharmacy
[3] Maastricht University Medical Centre,Department of Internal Medicine
[4] Hasselt University,Faculty of Medicine and Life Science
[5] Viecuri Medical Centre,Department of Internal Medicine
[6] Viecuri Medical Centre,Department of Clinical Pharmacy
[7] Aalborg University Hospital,Departments of Clinical Medicines and Endocrinology
[8] Steno Diabetes Center North Jutland,MRC Lifecourse Epidemiology Unit
[9] Southampton General Hospital,Division of Pharmacoepidemiology and Clinical Pharmacology
[10] Utrecht Institute of Pharmaceutical Sciences,NUTRIM
[11] Cardiovascular Research Institute Maastricht (CARIM),School for Nutrition and Translational Research in Metabolism
[12] Maastricht University,undefined
来源：
Osteoporosis International | 2022年 / 33卷
关键词：
Glucocorticoids; Fracture; Bone; Myasthenia gravis; Case–control study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：649 / 658
页数：9
相关论文
共 50 条
  • [1] The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis
    Safipour, Zohreh
    van Der Zanden, Rogier
    van den Bergh, Joop
    Janssen, Paddy
    Vestergaard, Peter
    de Vries, Frank
    Driessen, Johanna H. M.
    OSTEOPOROSIS INTERNATIONAL, 2022, 33 (03) : 649 - 658
  • [2] Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis
    O. A. Oshagbemi
    J. H. M. Driessen
    A. Pieffers
    E. F. M. Wouters
    P. Geusens
    P. Vestergaard
    J. van den Bergh
    F. M. E. Franssen
    F. de Vries
    Osteoporosis International, 2017, 28 : 2859 - 2866
  • [3] Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis
    Oshagbemi, O. A.
    Driessen, J. H. M.
    Pieffers, A.
    Wouters, E. F. M.
    Geusens, P.
    Vestergaard, P.
    van den Bergh, J.
    Franssen, F. M. E.
    de Vries, F.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (10) : 2859 - 2866
  • [4] Risk of fracture in patients with myasthenia gravis: a nationwide cohort study in Korea
    Park, Hye-Sun
    Kim, Kyoungsu
    Yu, Min Heui
    Shin, Ha Young
    Rhee, Yumie
    Kim, Seung Woo
    Hong, Namki
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 (06) : 688 - 696
  • [5] Oral function in patients with myasthenia gravis
    Donskov, Agnete Overgaard
    Shimoda, Akiko
    Vinge, Lotte
    Svensson, Peter
    Andersen, Henning
    PEERJ, 2021, 9
  • [6] Ten-year fracture risk in Japanese patients with myasthenia gravis: A comprehensive assessment using the fracture risk assessment tool
    Konno, Shingo
    Uchi, Takafumi
    Kihara, Hideo
    Sugimoto, Hideki
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 460
  • [7] The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis
    Lin, Chien-Ju
    Lee, Yu-Shan
    Yeh, Jiann-Horng
    Liu, Shu-Jung
    Lin, Kuan-Yu
    OSTEOPOROSIS INTERNATIONAL, 2024, 35 (10) : 1709 - 1717
  • [8] Fracture Risk in Patients with Myasthenia Gravis: A Population-Based Cohort Study
    Kassardjian, Charles
    Widdifield, Jessica
    Paterson, J. Michael
    Kopp, Alexander
    Nagamuthu, Chenthila
    Barnett, Carolina
    Tu, Karen
    Breiner, Ari
    JOURNAL OF NEUROMUSCULAR DISEASES, 2021, 8 (04) : 625 - 632
  • [9] Risk of diabetes mellitus among patients with myasthenia gravis
    Yeh, J. -H.
    Chen, H. -J.
    Lin, C. -C.
    Chen, Y. -K.
    Chiu, H. -C.
    Kao, C. -H.
    ACTA NEUROLOGICA SCANDINAVICA, 2015, 132 (02): : 132 - 138
  • [10] Fracture rate in patients with myasthenia gravis: the general practice research database
    Pouwels, S.
    de Boer, A.
    Javaid, M. K.
    Hilton-Jones, D.
    Verschuuren, J.
    Cooper, C.
    Leufkens, H. G.
    de Vries, F.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (02) : 467 - 476
12345